BioMed Research International

Animal Models of Human Pathology 2012

Publishing date
08 Jun 2012
Submission deadline
09 Dec 2011

Lead Editor

1Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy

2NeuroEndocrine Interactions in Rheumatology and Inflammatory Diseases, Santiago University Clinical Hospital, Santiago de Compostela, Spain

3Department of Molecular Virology, Immunology & Medical Genetics, The Ohio State University, Columbus, OH, USA

Animal Models of Human Pathology 2012


Based on the genetic alterations found in humans, multiple models of human pathologies have been generated in genetically engineered or drug-induced animals. These experimental models are valuable tools for understanding physiopathology of the disease and discovering novel therapeutic targets and drugs. In fact, one avenue holding tremendous potential to find therapies against human diseases is the use of intact living systems, where complex biological processes can be examined.

We invite authors to present original research articles as well as review articles that will stimulate the continuing efforts in developing animal models, ranging from invertebrates to large animals, to be used in preclinical applications, improving therapy in various fields of medicine (oncology, cardiovascular, immunology, endocrinology, brain pathologies, etc.). We are particularly interested in manuscripts that report naturally occurring, induced, or engineered animal models of human diseases and their preclinical applications. Reviews that summarize all the animal models for a particular pathology, their involvement in preclinical trials, and their future on treatment practice are also particularly welcome. Potential topics include, but are not limited to:

  • Modeling retinoblastoma in rodents
  • The use of animal models in the study of obesity
  • The value of animal models for drug development in autoimmune diseases
  • The genetics of cardiovascular disease: new insights from animal models
  • Understanding pathogenesis and therapy of ataxia telangiectasia (AT) via animal models
  • Experimental animal models of rheumatoid arthritis, lupus erythematosus, and osteoarthritis
  • Small model organisms for neurodegenerative diseases
  • Large animal models of heart failure
  • The pig: a representative animal model for humans
  • Modeling human disease using the nematode Caenorhabditis elegans
  • Drosophila models of human diseases

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

BioMed Research International
 Journal metrics
See full report
Acceptance rate26%
Submission to final decision76 days
Acceptance to publication22 days
Journal Citation Indicator-
Impact Factor-

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.